Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2000
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373447A1 Permeabilizing biofilms
11/16/2000CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372704A1 Use of phthalazine derivatives
11/16/2000CA2370801A1 1,5-benzodiazepine derivatives as cck-a receptor agonists
11/16/2000CA2369333A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/15/2000EP1051975A1 Dry mix formulation for bisphosphonic acids
11/15/2000EP1051972A1 Nitric oxide donor composition and method for treatment of anal disorders
11/15/2000EP1051431A1 Thrombin inhibitors
11/15/2000EP1051415A1 Benzamide derivatives as vasopressin antagonists
11/15/2000EP1051403A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/15/2000EP1051395A1 Hydroxamic and carboxylic acid derivatives
11/15/2000EP1051192A2 Methods for the prevention and treatment of fibrosis and sclerosis
11/15/2000EP1051174A1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
11/15/2000EP1051173A1 Derivatives of 1,3,4-oxadiazolone
11/15/2000EP1051167A1 Pharmaceutical uses of optically pure (-) -bupropion
11/15/2000EP1051166A1 Pharmaceutical uses of optically pure (+) -bupropion
11/15/2000EP0717635B1 Methods for regulating gastrointestinal motility
11/15/2000CN1273533A I (Robinia Pseudoacacia) lectin and its uses
11/15/2000CN1273118A Chinese medicine for treating dental disease and its preparing process `
11/15/2000CN1273105A Application of compound Bijiaruangan tablet in treating chronic hepatitis B and hepatic fibrosis
11/15/2000CN1273104A Chinese medicine for treating hepatitis B and hepatic fibrosis and its preparing process
11/15/2000CN1273103A Chinese-medicinal pill for treating hepatism
11/15/2000CN1273097A Bacillus preparation and its preparing process and usage
11/15/2000CN1058410C Traditional Chinese medicine preparation for curing liver-gallbladder disease
11/15/2000CN1058407C Medicine for treatment of gastropathy
11/15/2000CN1058404C Medicine for treatment of hepatitis B
11/15/2000CN1058394C Method for pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ
11/14/2000US6147224 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147111 Kidney, brain, and cardiovascular disorders; vasodilation
11/14/2000US6147109 Treating impotency; brain, cardiovascular, respiratory system and gastrointestinal disorders
11/14/2000US6147103 Extremely low residual solvent content
11/14/2000US6147096 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
11/14/2000US6147093 Optically pure (+) isomer of norcisapride used for treatment of disorders caused by gastrointestinal motility dysfunction
11/14/2000US6147061 Antiarthritic agents; anticancer agents; oral diseases
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146634 Proteins with urease activity
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066629A1 Modified exendins and exendin agonists
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066611A1 Steroid derivatives
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066555A1 Thio-oxindole derivatives
11/09/2000WO2000066170A1 Prucalopride oral solution
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066107A2 Antimalarian agents for the treatment of asthma
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000066093A2 Combined preparations comprising morpholine anthracyclines and anticancer agent
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066082A1 Anti-nausea compositions and methods
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000041463A3 Combination of hepatitis b vaccine with antiviral agents
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000028033A3 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
11/09/2000WO2000021509A3 Methods of treatment
11/09/2000WO2000019989A3 Use of catechol derivatives as proteinase inhibitors
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO1999056769A3 Inhibition of helicobacter pylori proliferation
11/09/2000DE19922443A1 Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen Use of dopamine D3 receptor ligands for the preparation of drugs for the treatment of renal dysfunction
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372225A1 Anti-nausea compositions and methods
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372214A1 Modified exendins and exendin agonists
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371642A1 Cyclic urea and cyclic amide derivatives
11/09/2000CA2371633A1 Thio-oxindole derivatives
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
1 ... 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 ... 1258